Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial

Perioperative chemotherapy improves overall survival (OS) and disease-free survival (DFS) compared with surgery alone in patients with resectable gastric adenocarcinoma (GA) or gastro-oesophageal junction adenocarcinoma (GEJA). The addition of trastuzumab to chemotherapy improves outcomes in patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer (1990) 2021-03, Vol.145, p.158-167
Hauptverfasser: Rivera, Fernando, Izquierdo-Manuel, Marta, García-Alfonso, Pilar, Martínez de Castro, Eva, Gallego, Javier, Limón, María Luisa, Alsina, María, López, Luis, Galán, Maica, Falcó, Esther, Manzano, José Luis, González, Encarna, Muñoz-Unceta, Nerea, López, Carlos, Aranda, Enrique, Fernández, Eva, Jorge, Mónica, Jiménez-Fonseca, Paula
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!